We found that, upon treatment with IM ± anti-VEGF, tumor endothelial cells expressed higher levels of Glycam1, which is expressed in mature HEVs (Figures 3J, S4J, and S4K). This evidence concerns the gene GLYCAM1 and neoplasm.